PPH VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| PPH | +10.9% | +8.6% | +17.4% | +21.8% | +16.6% | +9.8% |
| Equity average (4725 funds) | -2.1% | +1.9% | +2830.7% | +65564.6% | +15.0% | +1.5% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$5K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| ELAN Elanco Animal Health Inc | 0.53% | $1.0M | $100K |
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LLY Eli Lilly & Co | 23.10% |
| 2 | MRK Merck & Co Inc | 12.12% |
| 3 | NVO Novo Nordisk A/S | 5.45% |
| 4 | MCK Mckesson Corp | 4.92% |
| 5 | PFE Pfizer Inc | 4.79% |
| 6 | TEVA Teva Pharmaceutical Industries Ltd | 4.66% |
| 7 | BMY Bristol-Myers Squibb Co | 4.41% |
| 8 | COR Cencora Inc | 4.40% |
| 9 | GSK Gsk Plc | 4.23% |
| 10 | AZN Astrazeneca Plc | 3.69% |
| 11 | ABBV Abbvie Inc | 3.67% |
| 12 | NVS Novartis Ag | 3.64% |
| 13 | SNY Sanofi Sa/France | 3.53% |
| 14 | HLN Haleon Plc | 3.35% |
| 15 | JNJ Johnson & Johnson | 3.28% |
| 16 | TAK Takeda Pharmaceutical Co Ltd | 2.79% |
| 17 | ZTS Zoetis Inc | 2.63% |
| 18 | VTRS Viatris Inc | 1.60% |
| 19 | JAZZ Jazz Pharmaceuticals Plc | 1.27% |
| 20 | AXSM Axsome Therapeutics Inc | 0.53% |
| 21 | ELAN Elanco Animal Health Inc | 0.53% |
| 22 | CORT Corcept Therapeutics Inc | 0.45% |
| 23 | DFTX Definium Therapeutics Inc | 0.40% |
| 24 | OGN Organon & Co | 0.26% |
| 25 | PPH Other/Cash | 0.16% |
| 26 | PRGO Perrigo Co Plc | 0.11% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Oct 1, 2026 | $0.3600 |
| Jul 1, 2026 | $0.6248 |
| Apr 1, 2026 | $0.8441 |
| Dec 29, 2025 | $0.3106 |
| Oct 1, 2025 | $0.3931 |
| Jul 1, 2025 | $0.6069 |
| Apr 1, 2025 | $0.5245 |
| Dec 27, 2024 | $0.4110 |
| Oct 1, 2024 | $0.4090 |
| Jul 1, 2024 | $0.3558 |
| Apr 1, 2024 | $0.5328 |
| Dec 27, 2023 | $0.3074 |
| Oct 2, 2023 | $0.3398 |
| Jul 3, 2023 | $0.3891 |
| Apr 3, 2023 | $0.6641 |
| Dec 28, 2022 | $0.2400 |
| Oct 3, 2022 | $0.2696 |
| Jul 1, 2022 | $0.2496 |
| Apr 1, 2022 | $0.4429 |
| Dec 29, 2021 | $0.2691 |
| Oct 1, 2021 | $0.3453 |
| Jul 1, 2021 | $0.2859 |
| Apr 1, 2021 | $0.3497 |
| Dec 29, 2020 | $0.2662 |
| Oct 1, 2020 | $0.2493 |
| Jul 1, 2020 | $0.2523 |
| Apr 1, 2020 | $0.3374 |
| Dec 30, 2019 | $0.1729 |
| Oct 1, 2019 | $0.2920 |
| Jul 1, 2019 | $0.2810 |
| Apr 1, 2019 | $0.3900 |
| Dec 27, 2018 | $0.2032 |
| Oct 1, 2018 | $0.2345 |
| Jul 2, 2018 | $0.2493 |
| Apr 2, 2018 | $0.3943 |
| Dec 27, 2017 | $0.1500 |
| Oct 2, 2017 | $0.2210 |
| Jul 3, 2017 | $0.3040 |
| Apr 3, 2017 | $0.4651 |
| Dec 28, 2016 | $0.1450 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in PPH in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error